D-Galactose pentaacetate
D-Galactose pentaacetate inhibits leucine-induced insulin release. D-Galactose pentaacetate can be used for the research of persistent hyperinsulinemia in childhood or insulinoma[1][2].
Product Specifications
CAS Number
[25878-60-8]
Product Name Alternative
Pentaacetyl-D-galactopyranose
UNSPSC
12352200
Hazard Statement
H302, H315, H319, H335
Target
Insulin Receptor
Type
Biochemical Assay Reagents
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/d-galactose-pentaacetate.html
Purity
98.0
Smiles
CC(O[C@H]1[C@H]([C@H](OC([C@@H]1OC(C)=O)OC(C)=O)COC(C)=O)OC(C)=O)=O
Molecular Formula
C16H22O11
Molecular Weight
390.34
Precautions
H302, H315, H319, H335
References & Citations
[1]W J Malaisse, et al. Inhibition of insulin release by alpha- and beta-D-galactose pentaacetate. Int J Mol Med. 1998 Sep;2 (3) :331-2.|[2]M M Kadiata, et al. Opposite effects of D-glucose pentaacetate and D-galactose pentaacetate anomers on insulin release evoked by succinic acid dimethyl ester in rat pancreatic islets. Life Sci. 1999;64 (9) :751-4.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
